title: The effect of phenylpropanolamine on blood pressure during upright bicycle exercise in normal subjects.
abstract: We studied the effect of a single oral dose (37.5 mg immediate release) of phenylpropanolamine (PPA) in six normal subjects during upright incremental bicycle exercise to symptom tolerance. The study was double blind and placebo controlled with a crossover design. The patients rested supine for 90 minutes after dosing, sat quietly on the bicycle for five minutes, and then began exercise. After PPA systolic blood pressure was increased during supine rest (135 +/- 14 mmHg vs 120 +/- 10 mmHg for placebo; P less than 0.01) and while sitting on the bicycle prior to exercise (131 +/- 8 mmHg vs 121 +/- 8 mmHg for placebo; P less than 0.05). However, PPA did not alter the expected increase in systolic blood pressure with progressive exercise. Systolic blood pressure at maximum exercise (254 +/- 43 watts) was 185 +/- 14 mmHg for PPA vs 182 +/- 13 mmHg for placebo (difference not significant). This suggests that the physiological factors controlling blood pressure during exercise (increased cardiac output, vasodilation of vessels in exercising muscles and vasoconstriction of non-exercising vascular beds) are not altered significantly by a dose of PPA sufficient to increase resting systolic blood pressure, at least in normal subjects.
authors.affiliation: Department of Medicine, Hennepin County Medical Center, Minneapolis, MN.
authors.forename: S F
authors.initials: SF
authors.lastname: Davies
authors.forename: C D
authors.initials: CD
authors.lastname: McArthur
authors.forename: D G
authors.initials: DG
authors.lastname: Husebye
authors.forename: M M
authors.initials: MM
authors.lastname: Maddy
authors.forename: M B
authors.initials: MB
authors.lastname: O'Connell
authors.forename: P R
authors.initials: PR
authors.lastname: Pentel
mesh_terms: D000328:Adult; D001794:Blood Pressure / Q000187:drug effects*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005080:Exercise Test; D006801:Humans; D008297:Male; D010665:Phenylpropanolamine / Q000494:pharmacology*; D011897:Random Allocation
chemical_list: D010665:Phenylpropanolamine